<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Linnea 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=50240></link><description><![CDATA[Linnea 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 20 Apr 2026 15:06:21 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2026/03/12_1028147215_20260303162644_9397446915.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Linnea Achieves CEP Certification for Cannabidiol Isolate]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1029679</link><description><![CDATA[RIAZZINO, Switzerland--(Business Wire/Korea Newswire)--Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP).  The CEP serves to attest that the quality of an active pharmaceutical ingredient (API) is adequately controlled by the monographs of the European Pharmacopoeia, ensuring its safety, quality and confor...]]></description><pubDate>Thu, 05 Mar 2026 09:20:00 +0900</pubDate></item><item><title><![CDATA[리네아, 칸나비디올 아이솔레이트에 대한 유럽약전 적합성 인증 획득]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1029680</link><description><![CDATA[리아치노, 스위스--(Business Wire/뉴스와이어)--리네아는 자사의 칸나비디올(Cannabidiol, CBD) 아이솔레이트가 유럽약전 적합성 인증서(Certificate of Suitability to the European Pharmacopoeia, CEP)를 획득했다고 발표했다.  CEP는 원료의약품(Active Pharmaceutical Ingredient, API)의 품질이 유럽약전(European Pharmacopoeia) 각 조항에 의해 적절히 관리되고 있음을 증명하며, 이를 통해 해당 성분이 유럽 내 ...]]></description><pubDate>Thu, 05 Mar 2026 09:20:00 +0900</pubDate></item></channel></rss>